Kidney Function Quantitative In Vitro Diagnostic Rapid Test Kits For Ngal Poct
  • Kidney Function Quantitative In Vitro Diagnostic Rapid Test Kits For Ngal Poct Manufacturers, Kidney Function Quantitative In Vitro Diagnostic Rapid Test Kits For Ngal Poct Factory, Supply Kidney Function Quantitative In Vitro Diagnostic Rapid Test Kits For Ngal Poct
  • Kidney Function Quantitative In Vitro Diagnostic Rapid Test Kits For Ngal Poct Manufacturers, Kidney Function Quantitative In Vitro Diagnostic Rapid Test Kits For Ngal Poct Factory, Supply Kidney Function Quantitative In Vitro Diagnostic Rapid Test Kits For Ngal Poct
  • Kidney Function Quantitative In Vitro Diagnostic Rapid Test Kits For Ngal Poct Manufacturers, Kidney Function Quantitative In Vitro Diagnostic Rapid Test Kits For Ngal Poct Factory, Supply Kidney Function Quantitative In Vitro Diagnostic Rapid Test Kits For Ngal Poct

Kidney Function Quantitative In Vitro Diagnostic Rapid Test Kits For Ngal Poct

Brand :Norman

Product origin :China

Delivery time :In one month

Supply capacity :100000000/month

NGAL rapid test kits by fluorensense immunoassay analyzer
1. The optimal marker for early diagnosis of acute kidney injury(AKI).
2. Independent risk index to evaluate.
3. Progression of chronic kidney disease(CKD).

NGAL rapid test kits by fluorensense immunoassay analyzer:


Methodology: Fluorescence  Immunoassay

Rheumatism fluorescence immunoassay


NGAL:                                                                                                             

1. The optimal marker for early diagnosis of acute kidney injury(AKI).

2. Independent risk index to evaluate.

3. Progression of chronic kidney disease(CKD).


NGAL urine Specs:

Methodology

Fluorescence Immunoassay

Specimen

5ul(urine)

Measuring range

5-1500ng/ml

Cut-off value

5ng/ml

Reaction time

15 minutes

Shelf life

12months


Clinical Significance:
1. Optimal indicator for early diagnosis of acute kidney injury.

2. Real-time risk stratification of acute kidney injury.

3. Treatment and detection of acute kidney injury and prognosis evaluation.


Performance analysis: Correlation analysis between Norman NGAL and Abbott NGAL.

 

Advantage                                                                                                      

1. High sensitivity:5ng/ml

2. High accuracy: 98% correlation with Abbott

3. Wide linear range:5-300ng/ml

4. Small sample size:5ul(urine)


Applicable Instruments: Fluorescence Immunoassay Analyzer


Fluorescent Immunoassays (FIA):                                                                   
1.Fluorescent Immunoassays are simply a different type of immunoassay.

2.The key variable is the biochemical technique used for detecting the binding of the "detection" antibody and the analyte molecule.


The advantages of a Fluorescent detection system:                                       

1. The advantages of a Fluorescent detection system have been known for many years. 
2. These include higher sensitivity detection of the analyte, simplified reagents and simpler assay designs.
3.Several breakthroughs have occurred over the past few years that have enabled the implementation of a fluorescent based immunoassay system at the point of care.


Product Name:

1. Methodology:Fluorescence  immunoassay.

2. The optimal marker for early diagnosis of acute kidney injury(AKI).

Package:                                                                                                         

1. Test card: Aluminum foil pouch 1pc/bag, desiccant

2. Package size: 25pcs/box


Test Method: Immunefluorescence techniques


Instruction for use :

1. Please read the manual and instrument operation carefully before using.
2. Check whether the equipment can operate regularly, and prepare other related materials. 
3. Allow the test device, PCT buffer and specimen balanced to room temperature (15-30ºC) prior to testing. 
4. Minimizing exposure to damp air.


Interpretation of test results:

1. The analysis of test results are accomplished by immune-fluorescence quantitative analyzer of our company's NORMAN series.

2. The concentration of NAGAL in the  samples can be read directly in the corresponding batch of ID card standard curve by fluorescence signal valuewe measured. The default results use ng/ml as a unit.


Test Procedure:

1. Open the Immune-fluorescence quantitative analyzer.

2. Check whether the batch number of IC card and reagent box is consistent, and then  insert IC card into the instrument to get the curve we wanted.

3 .Remove the test device from the protective pouch and place it on a flat surface. Draw in 5μl of urine sample to the centrifugal tube, and dilute with 90μl of diluents. After gently mix the sample, add 90μl of diluted sample into the sample well. Place the test strip at room temperature for 5 minutes.

4. Insert the test card into the hole of immune-fluorescence quantitative analyzer, and click start, the instrument will scan the test card automatically.

5. Immune-fluorescence quantitative analyzer detects results automatically and calculates the content of NGAL in the sample.

6. Specimens, used strip and transfer pipettes may be potentially infectious. Proper handling and disposal methods should be established by the laboratory direction in accordance with local regulations.


About us:                                                                                                       

1. Nanjing Norman Biological Technology Co., Ltd is dedicated to R&D and manufacturing of automated chemiluminescence system. Founded in 2008, Norman biological has been upholding the idea that R&D shapes future ,and concentration determines success. Ever since the beginning, Norman has been focusing on developing and manufacturing chemiluminescence instruments and reagents.

2. Norman's manufacture center is located in the Yuhua District and owns an over 2,000m2 GMP-approved clean workshop. The R&D base, which is over 2,000m2 ,is located in state-level new

Jiangbei district. Now there are over 100 R&D engineers, 40% of which hold a PhD or master's degree.

3. Powered by advanced technology and excellent talents in the IVD field, Norman has been consistently improving its innovation platform , and increasing R&D investment. Self-innovation, combined with

long-term strategic cooperation with universities and research institutes and with outsourced technologies, ensures consistent improvement on product quality. 

4. Norman's R&D field has covered instruments, reagents, and raw materials, and has been entrusted by the Nanjing government to build a R&D center specialized in biological chemistry and immunity diagnosis. Up to now, Norman has acquired over 20 patents.

5. Being an expert in automated chemiluminescence analysis , Norman owns independent and completed intellectual property rights, and its products providetop-notch sensitivity, precision and accuracy . Thanks to the self-developed antigens and self-manufactured antibodies, Norman's products features minimized intra-and inter- batch difference.

6. R&D shapes future, and concentration determines success. Driven by the commitment to "provide complete solution to improve human health.Norman will consistently do its utmost to drive the IVD industry forward and contribute more to human health.

Rapid Test Kits For Ngal Poct

In Vitro Diagnostic


Agent Wanted: If you are interested in working with us, please feel free to contact. 


OEM will be highly welcome!


Welcome to our website!


Get the latest price? We'll respond as soon as possible(within 12 hours)
close left right